The FDA has issued a request for information regarding testosterone replacement therapy for men, seeking input from the public and stakeholders. This initiative aims to gather perspectives that will inform future regulatory considerations.
The Food and Drug Administration (FDA, the Agency, or we) is announcing a request for information from interested parties and the public to share their perspectives with FDA on testosterone replacement therapy for men. The Agency intends to use the information submitted to help inform considerations related to testosterone therapy for men.
Original title: “Food and Drug Administration Expert Panel on Testosterone Replacement Therapy for Men; Request for Information”